CYP2D6 genotype may moderate measures of brain structure in methamphetamine users
- 6 August 2020
- journal article
- research article
- Published by Wiley in Addiction Biology
- Vol. 26 (3) , e12950
Abstract
Chronic methamphetamine use is linked to abnormalities in brain structure, which may reflect neurotoxicity related to metabolism of the drug. As the cytochrome P450 2D6 (CYP2D6) enzyme is central to the metabolism of methamphetamine, genotypic variation in its activity may moderate effects of methamphetamine on brain structure and function. This study explored the relationship between CYP2D6 genotype and measures of brain structure and cognition in methamphetamine users. Based on the function of genetic variants, a CYP2D6 activity score was determined in 82 methamphetamine‐dependent (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [DSM‐IV] criteria) and 79 healthy‐control participants who completed tests of cognitive function (i.e., attention, memory, and executive function); most were also evaluated with structural magnetic resonance imaging (MRI) (66 methamphetamine‐dependent and 52 controls). The relationship between CYP2D6 activity score and whole brain cortical thickness differed by group (interaction p = 0.024), as increasing CYP2D6 activity was associated with thinner cortical thickness in the methamphetamine users (β = −0.254; p = 0.035), but not in control subjects (β = 0.095; p = 0.52). Interactions between CYP2D6 activity and group were nonsignificant for hippocampal volume (ps > 0.05), but both hippocampi showed trends similar to those observed for cortical thickness (negative relationships in methamphetamine users [ps < 0.05], and no relationships in controls [ps > 0.50]). Methamphetamine users had lower cognitive scores than control subjects (p = 0.007), but there was no interaction between CYP2D6 activity score and group on cognition (p > 0.05). Results suggest that CYP2D6 genotypes linked to higher enzymatic activity may confer risk for methamphetamine‐induced deficits in brain structure. The behavioral consequences of these effects are unclear and warrant additional investigation.Keywords
Funding Information
- National Institutes of Health (R21 DA034928, K23 DA 927734, UL1TR000124, P20 DA 022539, R01 DA 020726, R01 DA 15179)
This publication has 54 references indexed in Scilit:
- Measurement and Reliability of Response InhibitionFrontiers in Psychology, 2012
- Different Forms of Self-Control Share a Neurocognitive SubstrateJournal of Neuroscience, 2011
- Methamphetamine users show greater than normal age‐related cortical gray matter lossAddiction, 2011
- Effect of Modafinil on Learning and Task-Related Brain Activity in Methamphetamine-Dependent and Healthy IndividualsNeuropsychopharmacology, 2011
- Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in miceBehavioural Pharmacology, 2010
- Withdrawal symptoms in abstinent methamphetamine‐dependent subjectsAddiction, 2010
- Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: Preliminary findingsJournal of the International Neuropsychological Society, 2010
- Global and local morphometric differences in recently abstinent methamphetamine-dependent individualsNeuroImage, 2010
- Striatal Dopamine D2/D3Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to ImpulsivityThe Journal of Neuroscience, 2009
- Dopamine Formation from Tyramine by CYP2D6Biochemical and Biophysical Research Communications, 1998